APP Gene Test for Dementia: Accuracy, Limits, Cost, and Next Steps

Find out if APP testing fits your family history, what results can and cannot tell you, and costs.

An APP gene test looks for inherited changes in the APP gene, which makes amyloid precursor protein and can cause early-onset familial Alzheimer disease. It detects variants with about 99.9% sensitivity, but cannot predict onset or rule out other dementia, costs vary widely, and counseling guides next steps.

The U.S. National Institute on Aging states in its Alzheimer's genetics fact sheet that the APP gene lies on chromosome 21 and pathogenic variants cause autosomal-dominant disease. Symptoms typically begin before age 65 and sometimes much earlier.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

Who is this test for?

This test fits families with early-onset familial Alzheimer disease, not most people with memory concerns. According to the National Institute on Aging and a JAMA Neurology NIA-LOAD/NCRAD study, less than 10% of Alzheimer cases are early-onset. Of those, 10-15% are attributed to APP, PSEN1 or PSEN2 combined, or roughly 0.1-1.0% of all Alzheimer cases.

Inheritance is direct when a variant is present. AlzForum, reporting Columbia University guidance, states a child of a carrier has a 50% chance of inheriting the variant. Carriers of these dominantly inherited genes face an almost 100% risk of Alzheimer disease, usually before age 60.

What does a positive result mean?

A positive result means the lab found a pathogenic APP variant. Laboratories advertise about 99.9% analytical sensitivity for APP sequencing, which reflects the ability to find a variant when it is present.

A positive result does not forecast the clinical course in a person without symptoms. The NCBI GeneReviews chapter on early-onset familial Alzheimer disease explains in its guidance on predictive testing that a finding cannot predict age of onset, severity, symptoms, or rate of progression.

Why doesn't a negative result rule out dementia?

An APP-only test examines only APP. DNA Labs India states on its APP test page that a negative result does not exclude Alzheimer disease or other dementia. PSEN1, PSEN2, APOE and non-genetic causes remain possible.

That limit matters for families with several affected relatives. A negative APP finding leaves other inherited and non-inherited explanations open. A counselor can explain whether broader testing fits the family pattern.

How much does it cost and what happens next?

Prices and scope differ by test type. DNA Labs UAE lists in its UAE test listing standalone APP testing at AED 4,400. DNA Labs India lists the same type of testing at INR 20,000 with results in 3-4 weeks, while Invitae billing materials reported via Fierce Biotech offered broad U.S. diagnostic panels at about $250 self-pay or generally $100 or less after insurance.

Guidelines from the American College of Medical Genetics and National Society of Genetic Counselors, available through their joint counseling guidelines, require pre- and post-test counseling for APP and PSEN testing. They recommend testing an affected relative first to confirm the familial variant before testing healthy at-risk relatives. The Alzheimer's Association also cautions healthy people against routine Alzheimer risk testing until counseling supports informed consent. Ask for pre-test counseling before giving a sample.

  • Seek pre-test counseling before giving a sample
  • Test an affected family member first when possible
  • Return for post-test counseling to review results

You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.